Medicines News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.09.17	New Drugs Approved In August (RTTNews)
31.08.17	AMGN's Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears (RTTNews)
30.08.17	Medicines Co.'s VABOMERE Approved By FDA For Adult Patients With CUTI (RTTNews)
28.08.17	Medicines Co. Announces New Data From ORION-1 Phase II Study Of Inclisiran (RTTNews)
21.08.17	Generic Drugs Stock Performance Review -- Patheon, Zoetis, Ironwood Pharma, and Medicines Co. (PR Newswire)
26.07.17	Positive Data IGNITEs TTPH, MDCO Makes A Good TANGO, Wait Continues For EGRX (RTTNews)
19.07.17	Technical Reports on Generic Drugs Equities -- Allergan, Ironwood Pharma, Medicines Co., and Catalent (PR Newswire)
12.06.17	Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma (PR Newswire)
06.06.17	Dr. Reddy's Launches Angiomax' Generic Bivalirudin For Injection In U.S. (RTTNews)
04.06.17	Medicines Co. To Cut 15% Of Workforce As It Discontinues IONSYS In The U.S. (RTTNews)
01.05.17	How These Generic Drugs Stocks are Faring? -- Medicines Co., Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
28.03.17	Research Reports Initiation on Generic Drugs Stocks -- Medicines, Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
20.03.17	AMGN On Watch, GALE Reports Positive Data, EBS Secures BARDA Contract (RTTNews)
03.03.17	Learn how to target a 58% return on AveXis Inc., or get option-trade ideas on Ionis Pharmaceuticals, The Medicines Co, Prothena and Tesaro Inc. or any stock you choose (PR Newswire)
06.02.17	ESPR, MDCO Riding High, New Uses For MRK's Old Drug, DBVT In Full Smile(e) (RTTNews)
30.01.17	Generic Drugs Stocks on Investors' Radar -- Ironwood Pharma, Medicines, Rigel Pharma, and Lannett (PR Newswire)
09.01.17	EXAS Abuzz, MACK Makes Deal With Ipsen, XENE Awaits Data (RTTNews)
20.12.16	How These Generic Drugs Stocks are Faring? -- Ironwood Pharma, Medicines, Lannett, and SCYNEXIS (PR Newswire)
08.11.16	MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It's Time To Cherish IONS (RTTNews)
06.10.16	ALNY's ENDEAVOUR Goes In Vain, ALQA Gains Big In After-Hrs, SCYX On The Move (RTTNews)
15.06.16	CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race (RTTNews)
03.06.16	AKAO Abuzz, AAAP Gets FDA Blessing, CORT Under Close Watch, Big Day For MBRX (RTTNews)
27.05.16	TTNP On A High, Double Blessing For NERV, AVIR In Trouble, SAGE Awaits Data (RTTNews)
09.05.16	Medicines Company To Divest Non-Core Cardiovascular Assets - Quick Facts (RTTNews)
04.04.16	The Medicines Company Announces Participation at 2016 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to be held April 9-12 in Amsterdam (Businesswire)
18.12.15	Medicines Co. To Sell Its Hemostatis Portfolio To Mallinckrodt - Quick Facts (RTTNews)
01.09.15	MATRIX Trial Results Presented at Hot Line Session of ESC Congress 2015 and Simultaneously Published in The New England Journal of Medicine (Businesswire)
01.09.15	Analysis from CHAMPION PHOENIX Trial Highlight the Efficacy of Cangrelor among Patients undergoing PCI via the Radial Approach (Businesswire)
30.08.15	ALN-PCS Phase 1 Clinical Trial Shows Positive Results (RTTNews)
24.08.15	The Medicines Company Announces Participation at 2015 European Society of Cardiology (ESC) Congress in London (Businesswire)
09.07.15	Medicines Co. Authorizes Generic Launch Of Angiomax (RTTNews)
23.06.15	FDA Approves Medicines Co.'s Antiplatelet Drug Used During Heart Procedure (RTTNews)
01.06.15	The Medicines Company Announces Results of Phase 1 Study for Novel Investigational Intravenous Anesthetic, ABP-700 (Businesswire)
01.05.15	MDCO Gets FDA Nod For 2 Products, EXEL Awaits METEOR Data, WX To Make History (RTTNews)
01.05.15	Medicines Co. : FDA Approves Raplixa To Help Control Bleeding During Surgery (RTTNews)
20.04.15	Medicines Co. Says FDA Okays New Formulation Of MINOCIN For Injection (RTTNews)
16.04.15	Celsion Warms Up, AMGN Gets FDA Nod, SKBI Put On Notice, VVUS Sues Teva (RTTNews)
15.04.15	Pre-market Movers For April 15 (INTC, DAL, GOOGL, BAC, NOK, ALU, MDCO) (RTTNews)
10.04.15	Medicines Tastes Bitter, EXEL Excels, ORPN Has A Blast, FWP For The Long Haul (RTTNews)
09.04.15	Medicines Expects Weak Angiomax Sales To Hurt Q1 Revenue; Stock Down 9% (RTTNews)
30.03.15	Medicines Company Receives Marketing Approval For EU Commission (RTTNews)
30.03.15	The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV® (oritavancin) and RAPLIXA™ (sealant powder) (Businesswire)
18.03.15	Unabhängige Studie bestätigt Senkung der Bivalirudin-assoziierten Mortalität und Blutungen bei Hoch-Risiko-Patienten mit akutem Koronarsyndrom, die sich einer PCI unterziehen (Businesswire)
26.01.15	New Drug Approvals - The Month That Was (RTTNews)
23.01.15	Medicines Co. Gets CHMP Positive Opinions For Kengrexal, Orbactiv And Raplixa (RTTNews)
23.01.15	The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV™ (oritavancin) and RAPLIXA™ (sealant powder) (Businesswire)
28.10.14	AEZS To Watch Out, RCPT Surges In Afterhours, CEMI Focuses On Ebola, PTIE Hurt (RTTNews)
07.08.14	BDSI Hoping To Deliver, MDCO Gets FDA Nod, TXMD On Watch, Busy Days Await NVAX (RTTNews)
09.07.14	The Medicines Company to Announce Second Quarter and First Half 2014 Financial Results on Wednesday, July 23, 2014 (Businesswire)
07.07.14	The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

25.11.19		Novartis-Aktie leicht im Plus, Medicines-Aktie springt an: Novartis wohl mit Medicines einig über Milliarden-Kauf
19.11.19		Medicines Co-Aktie +20%: Novartis angeblich an Medicines Co. interessiert

25.11.19

Novartis-Aktie leicht im Plus, Medicines-Aktie springt an: Novartis wohl mit Medicines einig über Milliarden-Kauf

19.11.19

Medicines Co-Aktie +20%: Novartis angeblich an Medicines Co. interessiert

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Medicines Co.

Aktien Top/Flop

Medicines Peer Group Nachrichten

Meistgelesene Nachrichten